BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chi X, Xiao H, Shi M, Cai G, Xie Y, Jiang J, Tian G, Wu S, Zhang C, Zhao P, Chen J. Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience. BMC Gastroenterol 2019;19:88. [PMID: 31196030 DOI: 10.1186/s12876-019-1005-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhao T, Mao L, Yu Z, Hui Y, Feng H, Wang X, Lin L, Fan X, Chen X, Wang B, Cao X, Sun C. Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine. Int Immunopharmacol 2021;91:107308. [PMID: 33383448 DOI: 10.1016/j.intimp.2020.107308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Liu Y, Zhang J, Yin Z, Zhu X, Xue L, Cao B. Compromise or not? A case report of successful treatment of pembrolizumab-induced hepatitis in a patient with non-small cell lung cancer with low-dose methylprednisolone and bicyclol. Thorac Cancer 2020;11:2023-30. [PMID: 32379397 DOI: 10.1111/1759-7714.13463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]